36
2
10
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1016L |
Aviptadil Acetate
醋酸阿肽地尔,阿肽地尔,Vasoactive Intestinal Peptide acetate salt |
RAAS; SARS-CoV | Endocrinology/Hormones; Microbiology/Virology |
Aviptadil Acetate (Vasoactive Intestinal Peptide acetate salt) 是模拟血管活性肠多肽类似物,具有血管舒张效应。它可诱导肺血管舒张并抑制血管 SMC 的增殖和血小板聚集。它可用于研究 SARS-CoV-2 引起的肺纤维化、肺动脉高压和呼吸衰竭。 | |||
T80866 |
VIP(Guinea pig) TFA
Vasoactive Intestinal Peptide, guinea pig TFA |
||
VIP Guinea pig TFA,作为一种胃肠激素,兼具神经递质功能,能够刺激胚胎生长,起到营养和有丝分裂因子的作用。 | |||
TP1016 |
Aviptadil
Vasoactive Intestinal Peptide (human, rat, mouse, rabbit, canine, porcine),阿肽地尔 |
||
Aviptadil (INN) is an analog of vasoactive intestinal polypeptide (VIP) for the treatment of erectile dysfunction. | |||
TP1174 |
Endothelin-2 (49-69), human
Human endothelin-2,Endothelin-2, human,Endothelin-2 (human, canine),人内皮素2 |
Others | Others |
Endothelin-2 (49-69), human (Human endothelin-2) 是一种由 21 个氨基酸组成的血管活性肽。它可与 G 蛋白连接的跨膜受体,ET-RA 和ET-RB 结合。 | |||
T68853 |
Diproteverine HCl
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
Diproteverine HCl 是具有抗心绞痛特性的新型钙拮抗剂,具有解痉活性和血管活性。 | |||
TP1627L |
Prepro VIP (111-122), human acetate
Prepro VIP (111-122), human acetate(123025-94-5 free base) |
Others | Others |
Prepro VIP (111-122), human acetate(123025-94-5 free base) 是一种前血管活性肠多肽 (VIP) 衍生肽,对应于残基 111-122。 | |||
TP2103L |
[D-p-Cl-Phe6,Leu17]-VIP acetate
|
Others | Others |
[D-p-Cl-Phe6,Leu17]-VIP acetate 是一种竞争性和选择性的血管活性肠肽 (VIP) 受体拮抗剂 (IC50 = 125.8 nM)。 | |||
TP1283L |
VIP(6-28)(human, rat, porcine, bovine) acetate
|
Others | Others |
VIP(6-28)(human, rat, porcine, bovine) acetate 是外源性血管活性肠肽 (VIP) 受体对颈上神经节 (SCG) 中 cAMP 作用的拮抗剂。 | |||
T37496L |
Alamandine TFA
|
RAAS | Endocrinology/Hormones |
Alamandine TFA 是肾素-血管紧张素系统 (RAS) 的成员,是一种血管活性肽,是 G 蛋白偶联受体 MrgD 的内源性配体。它通过抗高血压作用来保护肾脏和心脏。 | |||
T4200 |
Sacubitril hemicalcium salt
AHU-377 (hemicalcium salt),LCZ696中间体,AHU377 calcium salt |
Neprilysin | Metabolism |
Sacubitril hemicalcium salt (AHU377 calcium salt) 是一种有效的 NEP 抑制剂,IC50=5 nM。它是研究心力衰竭药物 LCZ696 的组分之一。 | |||
T0317L |
Buflomedil
Buflomedilum |
Others | Others |
Buflomedil is a vasoactive compound. Buflomedil has been used for peripheral arterial diseases. | |||
TP2103 |
[D-p-Cl-Phe6,Leu17]-VIP
|
||
Selective vasoactive intestinal peptide (VIP) receptor antagonist (IC50 = 125.8 nM). Displays no activity on glucagon, secretin or GRF receptors. | |||
TP2143 |
Endothelin-2 (49-69), human TFA
Endothelin-2 (49-69) (human, canine) TFA,Human endothelin-2 TFA |
Others | Others |
Endothelin-2 (49-69), human (TFA) is a 21-amino acid vasoactive peptide that binds to ET-RA and ET-RB. | |||
TP1627 |
Prepro VIP (111-122), human
|
||
Prepro VIP (111-122), human is a prepro-vasoactive intestinal polypeptide (VIP)–derived peptide, corresponding to residues 111-122. | |||
TP1173 |
Endothelin 3 (Rat,Human) (TFA)
Endothelin-3, human, mouse, rabbit, rat TFA |
||
Endothelin-3, human, mouse, rabbit, rat TFA is a 21-amino acid vasoactive peptide that specifically interacts with G-protein-linked transmembrane receptors, ET-RA and ET-RB. | |||
T27042 |
Clobenoside
Ba-43853,Ba 43853,Ba43853 |
Others | Others |
Clobenoside is a non-steroidal anti-inflammatory agent. Clobenoside also has an edema-protective effect while not influencing blood pressure nor heart rat and not producing any direct vasoactive effects. | |||
TP1635 |
Prepro VIP (81-122), human
|
||
Prepro VIP (81-122), human is a prepro-vasoactive intestinal polypeptide (VIP) derived peptide, corresponding to residues 81-122. | |||
TP1283 |
VIP(6-28)(human, rat, porcine, bovine)
|
||
VIP(6-28)(human, rat, porcine, bovine) is a potent antagonist that effectively counteracts the effects of exogenous vasoactive intestinal peptide (VIP) on cyclic adenosine monophosphate (cAMP) signaling. | |||
T41088 |
Diadenosine pentaphosphate pentalithium
|
Others | Others |
Diadenosine pentaphosphate pentalithium is an endogenous vasoactive purine dinucleotide, isolated from thrombocytes. It is a member of the diadenosine polyphosphates (ApnA, n=2–7) and is found in secretory vesicles of platelets, chromaffin cells, Torpedo synaptic terminals, and brain synaptosomes. | |||
T36635 |
[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human)
[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human) |
||
[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human) 是GRF的 类似物,是一种血管活性肠肽 (VIP) 拮抗剂。 | |||
T80865 |
VIPhyb
|
||
VIPhyb(VIP Antagonist)是针对血管活性肠多肽(VIP)受体的拮抗剂,主要用于非小细胞肺癌(NSCLC)等癌症的科学研究。 | |||
T37309 |
Diadenosine pentaphosphate pentaammonium
|
Others | Others |
Diadenosine pentaphosphate pentaammonium, an endogenous vasoactive purine dinucleotide isolated from thrombocytes, is one component of the diadenosine polyphosphates (ApnA, n=2-7) family. These compounds are found in secretory vesicles, including those in platelets, chromaffin cells, Torpedo synaptic terminals, and brain synaptosomes[1][2]. | |||
T37310 |
Diadenosine pentaphosphate pentasodium
|
Others | Others |
Diadenosine pentaphosphate pentasodium, an endogenous vasoactive purine dinucleotide isolated from thrombocytes, serves as a key component of secretory vesicles in platelets, chromaffin cells, Torpedo synaptic terminals, and brain synaptosomes. This compound, along with other diadenosine polyphosphates (ApnA, n=2-7), plays a crucial role in physiological processes[1][2]. | |||
T83195 |
Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27)
|
||
Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27),是一种血管活性肠肽,起到VIP1受体拮抗剂的作用。 | |||
TP1054 |
PACAP (1-38), human, ovine, rat TFA
Pituitary Adenylate Cyclase Activating Polypeptide 38 (TFA) |
||
PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP), gastrin releasing peptide (GRP), | |||
T80876 |
Vasomera
|
||
Vasomera是一種穩定的長效血管活性腸肽(VIP)激動劑,主要作用於G蛋白偶聯的VPAC2受體,適用於與肌肉營養不良症相關的心肌病研究。 | |||
T36428 |
PACAP-related Peptide (human) (trifluoroacetate salt)
|
PACAP | GPCR/G Protein |
PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin , glucagon , glucagon-like peptide-1 , GLP-2 , and pituitary adenylate cyclase-activating polypeptide . It is expressed in normal human pancreas and adrenal gland tissue and in some tumors that produce vasoactive intestinal peptide (VIP). PRP (1-29) is secreted by CHO-K1 cells that express human recombinant preproPACAP. | |||
T82217 |
Helospectin I
|
||
Helospectin I属于血管活性肠肽(VIP)家族的一种神经肽,能够引起血管扩张,具有抗高血压效果,可用于降低血压。该化合物最早是从Heloderma suspectum蜥蜴的唾液腺毒液中分离得到。 | |||
T83491 |
[K15,R16,L27]VIP(1-7)/GRF(8-27)
|
||
[K15,R16,L27]VIP(1-7)/GRF(8-27)作为VIP1激动剂,对人类VIP1、大鼠VIP1及大鼠VIP2的结合IC50分别为2 nM、1 nM和30000 nM。 | |||
T78003 |
[D-p-Cl-Phe6,Leu17]-VIP TFA
|
||
[D-p-Cl-Phe6,Leu17]-VIP TFA,为竞争性及选择性血管活性肠肽(VIP)受体拮抗剂,其IC50为125.8 nM。该化合物针对胰高血糖素、促胰液素和GRF受体均不表现活性。 | |||
T80069 |
PACAP (6-27) (human, ovine, rat)
Pituitary adenylate cyclase-activating peptide (6-27) |
||
PACAP (6-27) (human, ovine, rat) 是一种对PACAP受体具有拮抗作用的化合物,可以抑制犬肾上腺对外源性VIP的反应。此化合物在心血管疾病和神经系统疾病研究中展现出应用潜力。 | |||
T82216 |
Helospectin II
|
||
Helospectin II,一种属于血管活性肠肽(VIP)家族的神经肽,具备血管扩张作用及抗高血压活性,能够降低血压。该化合物最初从蜥蜴Heloderma suspectum的唾液腺毒液中分离得到。 | |||
T78035 |
[K15,R16,L27]VIP(1-7)/GRF(8-27) acetate
|
||
[K15,R16,L27]VIP(1-7)/GRF(8-27)(acetate)为[K15,R16,L27]VIP(1-7)/GRF(8-27)的醋酸盐形态,作为VIP1激动剂,与人类和大鼠的肠血管活性肽1 (VIP 1) 及大鼠的肠血管活性肽2 (VIP 2) 的结合IC50值分别为2 nM、1 nM和30000 nM。 | |||
T81571 |
PACAP (1-38) free acid TFA
|
||
PACAP (1-38) free acid TFA,一种内源性神经肽,能有效促进胃窦运动,增强体液蛋白分泌,同时抑制胃泌素释放。此外,它刺激血管活性肠肽、胃泌素释放肽和P物质的释放,并通过RACK1增强N-甲基-D-天门冬氨酸受体功能及脑源性神经营养因子表达。 | |||
T76305 |
[Ala2] Endothelin-3, human
|
||
[Ala2] Endothelin-3, human 为ET-3的线性类似物,其结构中的Cys残基被Ala所替代。ET-3是由人体横纹肌肉瘤细胞系产生,且仅在此细胞系中表达的一种具有血管活性的肽。在非肌肉来源的肉瘤细胞系中不表达。该肽能够作为旁分泌因子,促进内皮细胞迁移。 | |||
T81572 |
PACAP (1-38) free acid
|
||
PACAP (1-38) free acid 是一种具有多重生物功能的内源性神经肽,主要作用包括刺激胃窦运动、增进体液蛋白分泌、抑制胃泌素分泌,以及促进血管活性肠肽、胃泌素释放肽和P 物质的释放。此外,PACAP (1-38) free acid 通过与RACK1互作,可以增强N-甲基-D-天门冬氨酸受体的功能并促进脑源性神经营养因子的表达。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4809 |
Pyrimidine
嘧啶,Metadiazine |
Others; Endogenous Metabolite | Metabolism; Others |
Pyrimidine (Metadiazine) 是内源性代谢产物的一种。 | |||
T7044 |
Norepinephrine
去甲肾上腺素,Levophed,Levonoradrenaline,Aktamin,Nor-Epirenan,Levonor,Arterenol |
MMP; Endogenous Metabolite; Adrenergic Receptor; Autophagy | Autophagy; GPCR/G Protein; Metabolism; Neuroscience; Proteases/Proteasome |
Norepinephrine (Levophed) 属于生物碱类天然产物,是一种神经递质,一种肾上腺素能受体 (AR) 的激动剂,对 α1、α2 和 β1 AR 具有激活活性。Norepinephrine 被用作抗休克的血管活性剂。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-03597 |
VIP Protein, Human, Recombinant (His)
PHM27,vasoactive intestinal peptide |
Human | HEK293 Cells |
VIP, or vasoactive intestinal peptide, is a neuropeptide of 28 amino acid residues that belongs to a glucagon/secretin superfamily, and it exerts its actions through three G-protein-coupled receptors (PAC1, VPAC1, and VPAC2). VIP is synthesized by trophoblast cells; it regulates trophoblast cell function and interaction with the major immune cell populations present in the pregnant uterus. | |||
TMPY-01120 |
VPAC2 Protein, Human, Recombinant (mFc)
VPCAP2R,PACAP-R-3,VIP-R-2,vasoactive intestinal pep... |
Human | HEK293 Cells |
VIP and PACAP receptor 2, or VIPR2 encodes the VPAC2 receptor, which binds both VIP and PACAP. VPAC2 is expressed throughout the central nervous system and the periphery. Mutations in the VIPR2 homolog in the mouse cause hypoactivity, as well as disruptions in circadian rhythm. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. | |||
TMPK-00766 |
KLKB1 Protein, Human, Recombinant (His)
PKK,Kininogenin,KLK3,KLKB1,Fletcher factor,Plasma kallikrein |
Human | HEK293 Cells |
Plasma kallikrein, also known as Fletcher factor or kallikrein B1 (KLKB1), is a serine endopeptidase, like its homologs tissue kallikrein and kallikrein-related peptidases (KLKs). Its physiological role is to catalyze the release of kinins and other vasoactive peptides. KLKB1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 70.3 kDa and the accession number is P03952. | |||
TMPH-02581 |
Chymase 1 Protein, Mouse, Recombinant (His)
Mast cell protease 5,Mast cell protease I,Alpha-chymase,Chym... |
Mouse | E. coli |
Major secreted protease of mast cells with suspected roles in vasoactive peptide generation, extracellular matrix degradation, and regulation of gland secretion. Chymase 1 Protein, Mouse, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 29.2 kDa and the accession number is P21844. | |||
TMPK-00857 |
KLKB1 Protein, Mouse, Recombinant (His)
Kininogenin,KLK3,Fletcher factor,Plasma kallikrein,KLKB1,PKK |
Mouse | HEK293 Cells |
Plasma kallikrein, also known as Fletcher factor or kallikrein B1 (KLKB1), is a serine endopeptidase, like its homologs tissue kallikrein and kallikrein-related peptidases (KLKs). Its physiological role is to catalyze the release of kinins and other vasoactive peptides. KLKB1 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 70.3 kDa and the accession number is P26262. | |||
TMPH-03328 |
Mcpt1 Protein, Rat, Recombinant (Myc)
Mast cell protease I,Mcpt1,Chymase,Mast cell protease 1,Chym... |
Rat | E. coli |
Major secreted protease of mast cells with suspected roles in vasoactive peptide generation, extracellular matrix degradation, and regulation of gland secretion. May participate in generating perivascular beta-protein which ultimately aggregates into amyloid-beta deposits. Mcpt1 Protein, Rat, Recombinant (Myc) is expressed in E. coli expression system with N-Myc tag. The predicted molecular weight is 28.6 kDa and the accession number is P09650. | |||
TMPK-00525 |
KLKB1 Protein, Cynomolgus, Recombinant (His)
KLK3,Plasma kallikrein,KLKB1,PKK,Kininogenin,Fletcher factor |
Cynomolgus | HEK293 Cells |
Plasma kallikrein, also known as Fletcher factor or kallikrein B1 (KLKB1), is a serine endopeptidase, like its homologs tissue kallikrein and kallikrein-related peptidases (KLKs). Its physiological role is to catalyze the release of kinins and other vasoactive peptides. KLKB1 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 70.19 kDa and the accession number is A0A2K5VTJ9. | |||
TMPJ-00475 |
Kallikrein 1/KLK1 Protein, Human, Recombinant (aa 19-262, His)
Tissue Kallikrein,Kidney/Pancreas/Salivary Gland Kallikrein,... |
Human | HEK293 Cells |
Kallikrein-1 (KLK1) is a member of human tissue Kallikrein family. Human KLK1 precursor contains a singal peptide (residues 1 to 18), a short pro peptide (residues 19 to 24) and a mature chain (residues 25 to 262). The function of KLK1 is to cleave Kininogen in order to release the vasoactive Kinin peptide (Lysyl-Bradykinin or Bradykinin). The Kinin peptide controls blood pressure reduction, vasodilation, smooth muscle relaxation and contraction, pain induction and inflammation. KLK1 also plays ... | |||
TMPY-00410 |
EPHX2 Protein, Human, Recombinant (His)
SEH,CEH,epoxide hydrolase 2, cytoplasmic |
Human | Baculovirus Insect Cells |
Genetic variation in EPHX2 was significantly associated with risk of incident CHD in Caucasians, implicating EPHX2 as a potential cardiovascular disease-susceptibility gene. Single nucleotide polymorphisms (SNPs) in the human EPHX2 gene had been implicated in susceptibility to cardiovascular disease, including stroke. The human EPHX2 mutations may in part explain the genetic variability in sensitivity to ischemic brain injury and stroke outcome. Epoxide hydrolase is involved in metabolism of vas... | |||
TMPY-02120 |
XPNPEP2 Protein, Human, Recombinant (His)
AEACEI,X-prolyl aminopeptidase (aminopeptidase P) 2, membran... |
Human | HEK293 Cells |
Aminopeptidase P (APP) is a hydrolase specific for N-terminal imido bonds, which are common to several collagen degradation products, neuropeptides, vasoactive peptides, and cytokines. A membrane-bound and soluble form of this enzyme (XPNPEP2) have been identified as products of two separate genes. XPNPEP2, the X-linked gene that encodes membranous aminopeptidase P (APP), has been reported to associate with APP activity. The membrane aminopeptidase P (XPNPEP2) is largely limited in distribution ... |